Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2021, 3(5); doi: 10.25236/FMSR.2021.030510.

The relationship between gut microbiota and Parkinson's disease

Author(s)

Ziyun Zhang

Corresponding Author:
Ziyun Zhang
Affiliation(s)

Branksome Hall,10 Spanhouse Cres. Markham,ON,L3R4E3,Canada

Abstract

The unique environment in the gut and its astounding microbiota creates an ecosystem that is unique to every individual living on this earth. There are more than enough studies done which proofs that the strong neuro-connection between the brain and the gut impact greatly to the daily decisions and motor functions of its host. Previous research has shown a bacterial tyrosine decarboxylase which converts levodopa(used to treat Parkinson’s patients) to dopamine can have great impacts on the hosts body. There are also researches that shows that in a germ-free gut microbiota, the model object is less likely to perform symptoms of Parkinson’s disease. The question waiting to be solved is: How can we isolate and cultivate healthy gut microbiota to find the key micro-organism that cures Parkinson’s disease. By filling in this gap using this research, scientists will be able to advance their way to finding cures for other untreatable disease. Not only will Parkinson’s patients benefit from this, many others who might have a critical condition could utilize this new method of medicine.

Keywords

Gut flora, gut microbiota, Parkinson’s disease, dementia, human microbiota, human microbiome, micro-organisms

Cite This Paper

Ziyun Zhang. The relationship between gut microbiota and Parkinson's disease. Frontiers in Medical Science Research (2021) Vol. 3 Issue 5: 62-65. https://doi.org/10.25236/FMSR.2021.030510.

References

[1] Van Kessel , S. P., El Aidy, S., van Dijk, G., Keshavarzian, A., Castejon, M., El-Gendy, A. O., & Frye, A. K. (2019, January 18). Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of parkinson's disease. PubMed.org.https://pubmed.ncbi.nlm.nih.gov/30659181/. 

[2] Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019, June 18). Gut microbiota in parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine.https://www.sciencedirect.com/science/article/pii/S235239641930372X. 

[3] Durack, J., & Lynch, S. V. (2019, January 7). The gut microbiome: Relationships with disease and opportunities for therapy. The Journal of experimental medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314516/#bib203. 

[4] Mayo Foundation for Medical Education and Research. (2020, December 8). Parkinson's disease. Mayo Clinic.https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055. 

[5] Paun, A., Yau, C., Meshkibaf, S., Daigneault, M. C., Marandi, L., Mortin-Toth, S., Bar-Or, A., Allen-Vercoe, E., Poussier, P., & Danska, J. S. (2019, February 1). Association of HLA-dependent ISLET autoimmunity with systemic antibody responses to Intestinal commensal bacteria in children. Science Immunology. https://immunology.sciencemag.org/content/4/32/eaau8125. 

[6] Romano, S., Savva, G. M., Bedarf, J. R., Charles, I. G., Hildebrand, F., & Narbad, A. (2021, March 10). Meta-analysis of the parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. Nature News. https://www.nature.com/articles/s41531-021-00156-z. 

[7] Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., Chesselet, M.-F., Keshavarzian, A., Shannon, K. M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., & Mazmanian, S. K. (2016, December 1). Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell.com.https://www.cell.com/cell/fulltext/S0092-8674(16)31590-2?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867416315902%3Fshowall%3Dtrue. 

[8] Shen, T., Yue, Y., He, T., Huang, C., Qu, B., Lv, W., & Lai, H.-Y. (1AD, January 1). The Association between the gut microbiota and Parkinson's disease, a meta-analysis. Frontiers. https://www.frontiersin.org/articles/10.3389/fnagi.2021.636545/full. 

[9] Statistics. Parkinson's Foundation. (n.d.). https://www.parkinson.org/Understanding-Parkinsons/Statistics. 

[10] Thomas, L. (2020, May 22). Gut bacteria Affecting parkinson's Treatment. News-medical. https://www.news-medical.net/health/Gut-Bacteria-Affecting-Parkinsone28099s-Treatment.aspx. 

[11] Wexler, M. (2021, March 15). Bacteria in patients' guts show changes that may weigh on disease. Parkinson's News Today. https://parkinsonsnewstoday.com/2021/03/15/parkinsons-microbiome-gut-bacteria-differs-may-affect-disease/. 

[12] Zhang, S., & Chen, D.-C. (2019, May 20). Facing a new challenge: The adverse effects of antibiotics on gut microbiota and host immunity. Chinese medical journal. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511407/. 

[13] Xinhuanet.(2018, March 10).Chinese scientists have found the gut bacterial groups that can help treat diabetes.Chinese scientists have found that the intestinal bacterial flora that can help treat diabetes-Xinhuanet.http://www.xinhuanet.com/tech/2018-03/10/c_1122516829.htm.